Saturday 07 January 2023 | 16:32 Eisai, Biogen get US FDA approval for Alzheimer’s drug, apply for full approval The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd 4523.T and Biogen Inc BIIB.O for patients in the ... By Reuters News Service
